Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising antiinfectives, antiparasitics, and other products for farm and companion animals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.

Krka, d. d.

MedClinic offers a comprehensive range of dental medical services in a familiar and warm environment, with modern equipment and nearly 20 years of experience. The clinic collaborates with dental practices across Europe to ensure high standards of dental treatments. It is involved in medical tourism in Romania.

MedClinic

Krka is a generic pharmaceutical company engaged in the development, production, marketing, and sales of prescription pharmaceuticals, non-prescription products, and animal health products. Self-described as one of the leading companies in its field.

Metric
Company Name	Krka, d. d.	MedClinic
Symbol	KRK
MSH ID	BIZ:KRKA	NET:MED-CLINIC
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Drug Manufacturers - Specialty & Generic	Dental Services
Country	SI	RO
Stage
Employee Count	12.68K
Website	krka.biz	med-clinic.net
LinkedIn
Founders

Metric
Market Cap	4.66B
Enterprise Value
Monthly Web Traffic		29.34K
Web Traffic Growth		0.71
Valuation
Raised Capital

Metric
Revenue	1.91B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.08B
EBITDA	526.47M
Operating Income	420.01M
Net Income	331.60M
EPS	10.71
Diluted EPS	10.71
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.59
Operating Profit Margin	0.22
EBITDA Margin	0.28
Net Profit Margin	0.20
Return on Equity	0.16
Return on Assets	0.12
Return on Capital Employed	0.17

KRK

BIZ:KRKA

Krka

Last Close

608.00

25/11 08:18

Market Cap

18.80B

Beta: -

Volume Today

15

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	12.00
P/B Ratio	1.70
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.55
EV Multiple	10.48

Metric
Days Sales Outstanding
Days Payables Outstanding	68.55
Days Inventory Outstanding	283.05
Operating Cycle	391.13
Cash Conversion Cycle	322.76
Asset Turnover	0.68

Metric
Operating Cash Flow	240.03M
Free Cash Flow	102.70M
Cash Flow to Debt	37.39
Operating Cash Flow/Sales	0.17
Free Cash Flow Yield	0.06

Metric
Cash & Equivalents	183.80M
Accounts Receivable	-109.99M
Inventory	638.62M
Goodwill	45.04M
Debt to Capitalization	0.01
Debt to Assets	0.00
Current Ratio	4.01
Quick Ratio	3.07

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.09
SG&A to Revenue	0.06